Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Hydroquinone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.67 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.62 |
| ▸ | HPGD | P15428 | 3/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.62 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.62 |
| ▸ | RECQL | P46063 | 2/20 | 0.62 |
| ▸ | THRB | P10828 | 2/20 | 0.62 |
| ▸ | CASP1 | P29466 | 2/20 | 0.62 |
| ▸ | TP53 | P04637 | 1/20 | 0.62 |
| ▸ | CA2 | P00918 | 5/20 | 0.61 |
| ▸ | CA1 | P00915 | 4/20 | 0.61 |
| ▸ | CA12 | O43570 | 3/20 | 0.61 |
| ▸ | CA9 | Q16790 | 3/20 | 0.61 |
| ▸ | CA5A | P35218 | 3/20 | 0.61 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.61 |
| ▸ | CA3 | P07451 | 3/20 | 0.61 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydroquinone SCHEMBL22190068 | 0.96 | LMNA (0.63) | LMNAALOX15HPGDALDH1A1CYP3A4 | |
| Hydroquinone SCHEMBL28381927 | 0.96 | LMNA (0.63) | LMNAALOX15HPGDALDH1A1CYP3A4 | |
| Hydroquinone SCHEMBL27973638 | 0.87 | LMNA (0.55) | LMNAALOX15HPGDALDH1A1CYP3A4 | |
| Hydroquinone SCHEMBL28903112 | 0.86 | ENPP2 (0.65) | LMNAALOX15HPGDALDH1A1CYP3A4 | |
| Hydroquinone SCHEMBL575590 | 0.86 | ENPP2 (0.65) | LMNAALOX15HPGDALDH1A1CYP3A4 | |
| 4-Aminophenol SCHEMBL17436623 | 0.85 | ALDH1A1 (0.72) | LMNAALOX15HPGDALDH1A1CYP3A4 | |
| P-Cresol SCHEMBL195722 | 0.85 | ACHE (0.72) | LMNAALOX15HPGDALDH1A1CYP3A4 | |
| Phenolsulfonic Acid SCHEMBL9682015 | 0.85 | LMNA (0.94) | LMNAALOX15HPGDALDH1A1CYP3A4 | |
| Parachlorophenol SCHEMBL29039840 | 0.85 | MAPK1 (0.58) | LMNAALOX15HPGDALDH1A1CYP3A4 | |
| Sulfuric Acid SCHEMBL8007761 | 0.85 | LMNA (0.67) | LMNAALOX15HPGDALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117822072-A | Tin-silver-copper alloy electroplating solution and electroplating method for wafer-level bump interconnection | 大连理工大学 | 2024-04-05 | — | — | CN | claimed |
| CN-116396449-A | Method for synthesizing polycarboxylate superplasticizer | 贵州凯襄新材料有限公司 | 2023-07-07 | — | — | CN | claimed |
| CN-116199839-A | Sulfonated polyether-ether-ketone polymer and preparation method thereof | 常州大学 | 2023-06-02 | — | — | CN | claimed |
| CN-112444581-B | High-safety hydroquinone composition purification method | 广东人人康药业有限公司 | 2023-03-17 | — | — | CN | claimed |
| CN-112022806-B | Water-in-oil hydroquinone emulsion and preparation method and application thereof | 广东人人康药业有限公司 | 2022-04-15 | — | — | CN | claimed |
| CN-111995500-B | Preparation method and application of high-safety hydroquinone composition | 广东人人康药业有限公司 | 2022-04-15 | — | — | CN | claimed |
| CN-112125785-B | High-safety hydroquinone composition purification method and application thereof | 广东人人康药业有限公司 | 2022-02-18 | — | — | CN | claimed |
| CN-112076096-B | Hydroquinone three-phase emulsion and preparation method and application thereof | 广东人人康药业有限公司 | 2021-12-28 | — | — | CN | claimed |
| US-20210353611-A1 | METHODS OF TREATING AMYOTROPHIC LATERAL SCLEROSIS | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2021-11-18 | — | — | US | claimed |
| EP-3852759-A2 | METHODS OF TREATING AMYOTROPHIC LATERAL SCLEROSIS | Yeda Research and Development Co. Ltd (IL) | 2021-07-28 | — | — | EP | claimed |
| CN-113038951-A | Method of treating amyotrophic lateral sclerosis | 耶达研究及发展有限公司 | 2021-06-25 | — | — | CN | claimed |
| CN-108251063-B | High-performance composite phase-change material and preparation method thereof | 有研工程技术研究院有限公司 | 2021-05-11 | — | — | CN | claimed |
| CN-112334165-A | Stabilized hyaluronic acid | 克罗马药品有限责任公司 | 2021-02-05 | — | — | CN | claimed |
| WO-2020058979-A2 | METHODS OF TREATING AMYOTROPHIC LATERAL SCLEROSIS | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2020-03-26 | — | — | WO | claimed |
| CN-101039683-A | Compositions and methods using hyaluronic acid and hyaluronidase inhibitors | ANGIOTECH INT AG (CH) | 2007-09-19 | — | — | CN | claimed |
| US-20260034086-A1 | Pet Food Compositions Comprising Caprylic Acid And Docosahexaenoic Acid And/Or Eicosapetaenoic Acid For Use In Treating Struvite Urolithiasis | HILL'S PET NUTRITION, INC. (US) | 2026-02-05 | — | — | US | disclosed |
| US-20250375505-A1 | COMPOSITIONS AND METHODS FOR MODIFYING BILE ACIDS TO REGULATE LIPID AND STEROID METABOLISM | UNIV CALIFORNIA (US) | 2025-12-11 | — | — | US | disclosed |
| US-4434226-A | CONCURRENT ADDITION OF SILVER, BROMIDE, IODIDE SALTS | EASTMAN KODAK COMPANY (US) | 1984-02-28 | — | — | US | disclosed |
| US-4433048-A | TABULAR GRAINS | EASTMAN KODAK COMPANY (US) | 1984-02-21 | — | — | US | disclosed |
| US-4414306-A | TABULAR GRAINS | EASTMAN KODAK COMPANY (US) | 1983-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250375505-A1 | COMPOSITIONS AND METHODS FOR MODIFYING BILE ACIDS TO REGULATE LIPID AND STEROID METABOLISM | CYP27A1, LIPC, CYP46A1 | LMNA 2028/4885ALOX15 632/4885HPGD 1089/4885 |
| US-20260034086-A1 | Pet Food Compositions Comprising Caprylic Acid And Docosahexaenoic Acid And/Or Eicosapetaenoic Acid For Use In Treating Struvite Urolithiasis | FPR2, FPR1, FPR3 | LMNA 1957/4885ALOX15 184/4885HPGD 427/4885 |
| US-20210353611-A1 | METHODS OF TREATING AMYOTROPHIC LATERAL SCLEROSIS | SMN1; SMN2, SOD1, OAT | LMNA 810/4885ALOX15 383/4885HPGD 754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.